Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT03115424
Clinical Trials · NCT03115424
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Completed
Phase 3
Liraglutide
(Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Mayo Clinic
Enrollment
46
Start date
Jun 2017
Locations
1 site, United States
Primary endpoint
Weight
View Liraglutide compound reference